| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |